Hertfordshire, England, July 08, 2025 (GLOBE NEWSWIRE) — With a $10 sign-up bonus, daily fixed income and zero maintenance fees, cloud mining is easier to get started than ever before OKALIO, a leading global digital asset infrastructure provider, today announced the official launch of Okaliomining, a new generation cloud mining platform designed to meet the […]
(NASDAQ:CETY), IRVINE, CA., July 08, 2025 (GLOBE NEWSWIRE) — Clean Energy Technologies, Inc. (Nasdaq: CETY) (the “Company” or “CETY”), a clean energy technology company offering power generation, waste to energy, battery storage, and heat to power solutions to deliver affordable, scalable, and eco-friendly energy, clean fuels, and alternative electricity for a sustainable future, is pleased
MTI Co., Ltd. (a NYK Group company), Mitsubishi Shipbuilding Co., Ltd., TSUNEISHI SHIPBUILDING Co., Ltd., Japan Agency for Marine-Earth Science and Technology, Japan Marine United Corporation, Mitsui E&S Co., Ltd., National Maritime Research Institute, TSUNEISHI AKISHIMA LABORATORY Co., Ltd. (formerly Akishima Laboratory Inc.), Graduate School of Engineering The University of Osaka and Kyoto University cooperatively
NEW YORK, NY / ACCESS Newswire / July 8, 2025 / If you suffered a loss on your Reckitt Benckiser Group plc (OTC PINK:RBGLY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/reckitt-benckiser-group-plc-lawsuit-submission-form?prid=155953&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at
NEW YORK, NY / ACCESS Newswire / July 8, 2025 / If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=155954&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / July 8, 2025 / If you suffered a loss on your Reddit, Inc. (NYSE:RDDT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/reddit-inc-lawsuit-submission-form?prid=155957&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / July 8, 2025 / If you suffered a loss on your Sarepta Therapeutics, Inc. (NASDAQ:SRPT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sarepta-lawsuit-submission-form?prid=155956&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / July 8, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=155955&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at
NEW YORK, NY / ACCESS Newswire / July 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Unicycive Therapeutics, Inc. ("Unicycive" or the "Company") (NASDAQ:UNCY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Unicycive and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of argenx SE ("argenx" or the "Company") (NASDAQ:ARGX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether argenx and certain of its officers and/or directors